Life Science Nation Newsletter | September 26, 2014 | Issue 81
|
|
Video: Five Family Offices Discuss Life Science Investment at RESI 3
|
Meeting Follow-Up: Why and How
|
Venture Philanthropy: Fast, Disciplined, and Getting People Started
|
Life Science Investor Mandates (Sept. 10 - Sept. 22)
|
|
|
Seeking Early Stage Therapeutics in for a Wide Range of Indications
|
Seeking to In-License Early Stage Therapeutic Assets
|
Seeking Later Stage Therapeutics, Devices and Diagnostics
|
|
|
By Dennis Ford, Founder & CEO, LSN
At LSN's third Redefining Early Stage Investments (RESI) Conference, leaders from five family offices around the world gathered under the same roof at Fenway Park, answering questions such as: Why do family offices invest directly? How do they assess early stage opportunities? How do you find family offices? How do you build a quality relationship with a family office? Do family offices do deals with third party fundraising partners? How important is branding and messaging?
Click on the video below to hear the views of these five family offices. The video is 70 minutes, and well worth the viewing time.
|
RESI 3 Family Office Panel
|
|
|
|
As an entrepreneur in the midst of a fundraising campaign and all that it entails-networking events, conferences, referrals, and cold calls-you are going to meet with a substantial number of people who are either potential investors in your technology or who could connect you with someone who is. Following up with these new contacts after an initial meeting or conversation can make or break your campaign. Here are some key reasons why following up is so crucial and what it can do for your campaign.
It Shows Professionalism
By taking the time to send follow-up messages to recent contacts, you are demonstrating your aptitude and professionalism as an entrepreneur. You are going to be managing potentially hundreds of relationships, and most people you speak to will be aware of that. So taking the time to send a personalized follow-up message in a timely manner shows your level of organization. This ultimately reflects positively on your investment opportunity. With investors viewing management as one of the most crucial pieces of any early stage life science investment, you need to do whatever you can to demonstrate you are on top of things....
|
|
|
By Shaoyu Chang, Research Analyst, LSN
Venture philanthropy investment is playing an increasingly important role in early stage life science innovation. More and more, nonprofit foundations are partnering with start-up companies to advance science and address unmet needs. At the recent Redefining Early Stage Investments Conference in Boston, leaders from five prominent foundations gathered for a discussion on the evolving landscape of venture philanthropy in life science research.
At a time when traditional funding sources for life science are on the decline, venture philanthropists are stepping in to fill some of the gaps. "We are looking at the emerging markets of tomorrow. They might not be big, but they are not inexistent" said a program investment officer with a leading foundation in global health. "We are trying hard to find the right mix of commercially viable companies that can serve our charitable goals."
|
|
|
|
|
Editors:
Nono Hu, Senior Manager, Branding & Messaging, LSN
|
|
|
|